FDA Inspection 961300 — Dendreon Pharmaceuticals LLC

Dendreon Pharmaceuticals LLC — FEI 3008821247

The FDA completed an inspection of Dendreon Pharmaceuticals LLC on Jan 22, 2016 in Seal Beach, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 22, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Seal Beach, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.